PD-L1-Inhibitor-Associated Hidradenitis Suppurativa.
0/5 보강
APA
Jin A, Steele KT, Chu EY (2026). PD-L1-Inhibitor-Associated Hidradenitis Suppurativa.. Journal of cutaneous pathology. https://doi.org/10.1111/cup.70068
MLA
Jin A, et al.. "PD-L1-Inhibitor-Associated Hidradenitis Suppurativa.." Journal of cutaneous pathology, 2026.
PMID
41645337 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.
- Risk of Cancer in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.
- Anti-PD-1/PD-L1 Immunotherapy as a Potential Treatment Option for Lung Cancer: A Perspective Analysis of Opportunities and Challenges.
- Cuproptosis and Disulfidptosis Converge to Empower PD-L1 Checkpoint Therapy via Cadict-Induced PD-L1 Translation.
- Choice of fixative affects programmed death-ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma.
- The Correlation Among PD-L1 Expression and the Driver Genes Status in Malignant Pleural Effusion of Lung Adenocarcinoma.